Aromatase Gene Expression in Endometrial Carcinoma
Author Information
Author(s): H Sasanol, K Kaga, S Sato, A Yajima, H Nagura, N Harada
Primary Institution: Tohoku School of Medicine, Sendai, Japan; Fujita-Gakuen Health University, Toyoaeke, Japan
Hypothesis
Does alternative splicing of the aromatase gene contribute to its overexpression in endometrial carcinoma?
Conclusion
The study found varying levels of aromatase expression in endometrial carcinoma, suggesting that alternative splicing may play a role in its regulation.
Supporting Evidence
- Strong aromatase immunoreactivity was found in stromal cells of carcinoma in five out of seven cases.
- Varying levels of aromatase transcripts were detected in five cases.
- Alternative splicing of the aromatase gene may contribute to its overexpression in endometrial carcinoma.
Takeaway
This study looked at how a gene that helps make estrogen behaves in certain types of cancer in the uterus, finding that it can act differently in different cases.
Methodology
The study used immunohistochemistry and RT-PCR to analyze aromatase gene expression in seven endometrial carcinoma specimens.
Limitations
The small sample size limits the generalizability of the findings.
Participant Demographics
The study included seven patients with endometrioid endometrial carcinoma, with ages ranging from 30 to 69 years.
Want to read the original?
Access the complete publication on the publisher's website